Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MURA
3726
DELISTED
Mural Oncology
MURA
| $363K | ﹤0.01% |
175,111
+350
| +0.2% | +$752 |
|
|
CMPS
3727
Compass Pathways
CMPS
$1.97B
| $361K | ﹤0.01% |
62,962
+35,340
| +128% | +$159K |
|
|
BNKK
3728
Bonk Inc
BNKK
$7.77M
| $360K | ﹤0.01% |
38,413
+24,642
| +179% | +$450K |
|
|
AMOD
3729
Alpha Modus Holdings
AMOD
$21.2M
| $360K | ﹤0.01% |
7,554
+6,200
| +458% | +$287K |
|
3730
Nephros
NEPH
$47.4M
| $359K | ﹤0.01% |
75,891
-17,296
| -19% | -$67.9K |
|
3731
vTv Therapeutics
VTVT
$125M
| $356K | ﹤0.01% |
15,298
+2,432
| +19% | +$42.7K |
|
3732
IGC Pharma
IGC
$29.8M
| $355K | ﹤0.01% |
852,444
+149,141
| +21% | +$56.7K |
|
3733
US Global Investors
GROW
$38.7M
| $353K | ﹤0.01% |
128,246
| – | – |
|
|
CFSB
3734
DELISTED
CFSB Bancorp
CFSB
| $351K | ﹤0.01% |
24,808
+166
| +0.7% | +$2.32K |
|
|
HEPS
3735
D-Market Electronic Services & Trading
HEPS
$1.01B
| $350K | ﹤0.01% |
130,255
+22,339
| +21% | +$62K |
|
|
AHT
3736
Ashford Hospitality Trust
AHT
$19.8M
| $349K | ﹤0.01% |
59,134
+273
| +0.5% | +$1.72K |
|
3737
Acrivon Therapeutics
ACRV
$73.6M
| $348K | ﹤0.01% |
192,033
+27,671
| +17% | +$38.9K |
|
3738
Zedge
ZDGE
$38.6M
| $348K | ﹤0.01% |
119,389
-297
| -0.2% | -$1.05K |
|
|
SOHU
3739
Sohu.com
SOHU
$369M
| $346K | ﹤0.01% |
22,115
| – | – |
|
|
STRR
3740
Star Equity Holdings
STRR
$40.1M
| $345K | ﹤0.01% |
30,995
+4,116
| +15% | +$38.8K |
|
3741
electroCore
ECOR
$84.7M
| $345K | ﹤0.01% |
69,629
+3,087
| +5% | +$18K |
|
3742
HUTCHMED
HCM
$2.13B
| $344K | ﹤0.01% |
21,833
| – | – |
|
|
ACFN
3743
Acorn Energy
ACFN
$46.1M
| $343K | ﹤0.01% |
+11,985
| New | +$331K |
|
3744
BioAtla
BCAB
$5.61M
| $341K | ﹤0.01% |
9,904
+59
| +0.6% | +$1.36K |
|
|
EXOZ
3745
eXoZymes Inc
EXOZ
$53.5M
| $340K | ﹤0.01% |
23,063
+2,464
| +12% | +$26.8K |
|
3746
OneMedNet
ONMD
$42.1M
| $340K | ﹤0.01% |
311,505
+174,885
| +128% | +$123K |
|
3747
Data I/O
DAIO
$30.8M
| $339K | ﹤0.01% |
101,615
+4,016
| +4% | +$13K |
|
|
CTOR
3748
Citius Oncology
CTOR
$75.5M
| $339K | ﹤0.01% |
167,172
+109,875
| +192% | +$238K |
|
3749
Cibus
CBUS
$144M
| $339K | ﹤0.01% |
262,713
+4,973
| +2% | +$7.2K |
|
|
NOAH
3750
Noah Holdings
NOAH
$588M
| $335K | ﹤0.01% |
28,900
+2,004
| +7% | +$24K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.